SABCS 2019 - oncoletter · lcm (34%) O nodes tumor and/or pgR.ve (64%) pertuzumab ER.ve and/or...
12
SABCS 2019
Transcript of SABCS 2019 - oncoletter · lcm (34%) O nodes tumor and/or pgR.ve (64%) pertuzumab ER.ve and/or...
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019
SABCS 2019